[Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use; D004357:Drug Synergism; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008082:Lipotropic Agents / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects
D005343:Fibrinolytic Agents; D008082:Lipotropic Agents; D009539:Nicotinic Acids; D000255:Adenosine Triphosphate; D006493:Heparin; D001205:Ascorbic Acid
Proposte per uno schema di terapia fibrinolitico chiarificante dell'arteriopatia obliterante periferica.